7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
https://doi.org/10.1136/annrheumdis-2023-eular.2991
Copy DOIJournal: Annals of the Rheumatic Diseases | Publication Date: May 30, 2023 |
BackgroundRandomized controlled trials have demonstrated the efficacy and safety of FIL for moderate to severe RA;[1–3] however, real-world evidence is lacking.ObjectivesTo evaluate the rationale for starting FIL in patients (pts)...
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.